Skip to content

Clinical trials

Recruiting Cardiomyopathy, Dilated trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathy, Dilated Status: Recruiting Country / region: China Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20191
20201
20211
20242
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Second Affiliated Hospital, Zhejiang University, School of Medicine3
Chinese Academy of Medical Sciences, Fuwai Hospital2
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology2
AstraZeneca1
China National Center for Cardiovascular Diseases1
Shandong Provincial Hospital1
Tongji Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathy, Dilated11
Heart Failure3
Cardiomyopathy, Hypertrophic2
Arrhythmogenic Right Ventricular Dysplasia1
Death, Sudden, Cardiac1
Myocardial Infarction1
Myocarditis1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.